Therwil, Switzerland

Klaus Ruedi


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus Ruedi: Innovator in Pharmacological Peptolides

Introduction: Klaus Ruedi, an accomplished inventor based in Therwil, Switzerland, has made significant contributions to the field of pharmacology. With a focus on innovative compounds that demonstrate crucial health applications, Ruedi holds a notable patent that highlights his commitment to advancing drug development.

Latest Patents: Klaus Ruedi's patent, titled "Pipecolic acid-containing peptolides, their preparation and - Pipecolic acid-containing peptolides," represents a groundbreaking leap in medicinal chemistry. This invention involves peptidic backbones comprising at least nine alpha-amino acid residues linked by peptide bonds. The innovation outlines effective methods of preparation through isolation or derivation from specific microorganism strains, such as S. 42508/F (NRRL 15761). The peptolides described exhibit promising pharmacological properties, including antifungal capabilities and the potential to reverse chemotherapeutic drug resistance, in addition to exhibiting immunosuppressant and anti-inflammatory effects.

Career Highlights: Klaus Ruedi is currently associated with Sandoz GmbH, a company known for its dedication to healthcare solutions and pharmaceuticals. Throughout his career, he has focused on developing new bioactive compounds that could significantly enhance therapeutic outcomes for patients.

Collaborations: Ruedi's work is further enriched through collaborations with esteemed colleagues such as Michael Morris Dreyfuss and Gerhard Emmer. By working alongside such talented professionals, Ruedi has been able to foster an environment of innovation and mutual support in his research efforts.

Conclusion: Klaus Ruedi is an exemplary inventor whose patent contributions have the potential to transform pharmacological treatments. By utilizing his expertise in peptolides, he has opened new avenues for medical advancement, highlighting the vital role of innovation in the healthcare sector. His collaboration with skilled professionals in the field signifies a strong network of support that drives forward-thinking discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…